State Board of Administration of Florida Retirement System bought a new stake in LeMaitre Vascular Inc (NASDAQ:LMAT) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 9,501 shares of the medical instruments supplier’s stock, valued at approximately $295,000.
A number of other hedge funds have also recently made changes to their positions in the stock. Texas Permanent School Fund increased its stake in shares of LeMaitre Vascular by 3.8% during the 1st quarter. Texas Permanent School Fund now owns 10,770 shares of the medical instruments supplier’s stock valued at $334,000 after acquiring an additional 390 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of LeMaitre Vascular by 2.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 20,726 shares of the medical instruments supplier’s stock worth $490,000 after purchasing an additional 480 shares during the period. Bank of Montreal Can grew its holdings in shares of LeMaitre Vascular by 99.1% during the 4th quarter. Bank of Montreal Can now owns 1,113 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 554 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of LeMaitre Vascular by 151.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,513 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 912 shares during the period. Finally, Comerica Bank grew its holdings in shares of LeMaitre Vascular by 2.8% during the 1st quarter. Comerica Bank now owns 56,306 shares of the medical instruments supplier’s stock worth $1,683,000 after purchasing an additional 1,512 shares during the period. 77.10% of the stock is owned by hedge funds and other institutional investors.
LMAT has been the subject of a number of analyst reports. BidaskClub upgraded LeMaitre Vascular from a “sell” rating to a “hold” rating in a report on Thursday, June 20th. ValuEngine upgraded LeMaitre Vascular from a “sell” rating to a “hold” rating in a report on Friday, April 26th. Zacks Investment Research upgraded LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Thursday, April 18th. Finally, Barrington Research reiterated a “buy” rating and set a $32.00 target price on shares of LeMaitre Vascular in a research note on Thursday, May 2nd. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $31.00.
LeMaitre Vascular (NASDAQ:LMAT) last announced its earnings results on Wednesday, May 1st. The medical instruments supplier reported $0.17 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by ($0.02). LeMaitre Vascular had a net margin of 20.92% and a return on equity of 16.76%. The firm had revenue of $28.48 million for the quarter, compared to the consensus estimate of $27.94 million. During the same period in the prior year, the business earned $0.19 EPS. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Equities research analysts anticipate that LeMaitre Vascular Inc will post 0.83 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, June 6th. Investors of record on Wednesday, May 22nd were paid a dividend of $0.085 per share. The ex-dividend date was Tuesday, May 21st. This represents a $0.34 annualized dividend and a yield of 1.22%. LeMaitre Vascular’s dividend payout ratio is currently 40.48%.
LeMaitre Vascular Profile
LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature.
Recommended Story: How is a price target determined?
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.